Published in Obesity and Diabetes Week, February 14th, 2005
K. Krzyzanowska and colleagues, University Hospital Rudolf Virchow, Vienna, Austria, wrote, "The endogenous nitric oxide-synthase inhibitor asymmetrical dimethyl-L-arginine (ADMA) is elevated in patients with increased risk for arteriosclerosis. Obesity is a risk factor for cardiovascular disease. We measured plasma ADMA concentrations in morbidly obese women before and after weight loss following gastroplastic surgery.
"ADMA and symmetrical dimethyl-L-arginine concentrations were analyzed by HPLC from 34 female patients (age...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.